Journal ArticlemedRxiv · September 1, 2024
BACKGROUND: Alternating hemiplegia of childhood (AHC) is a rare disorder with both neurologic and cardiac manifestations. The ATP1A3-D801N variant is associated with a pathologically short QT interval and risk of ventricular arrhythmia following bradycardi ...
Full textLink to itemCite
Journal ArticlemedRxiv · July 31, 2024
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition affecting ~1 in 500 and exhibits marked genetic heterogeneity. Previously published in 2019, 57 HCM-associated genes were curated providing the first systematic evaluation of g ...
Full textLink to itemCite
Journal ArticlePediatr Res · July 5, 2024
BACKGROUND: Despite advances in treatment and survival, individuals with congenital heart defects (CHD) have a higher risk of heart failure (HF) compared to the general population. OBJECTIVE: To evaluate comorbidities associated with HF in patients with CH ...
Full textLink to itemCite
ConferencePediatr Cardiol · June 2024
Adults with congenital heart disease (CHD) benefit from cardiology follow-up at recommended intervals of ≤ 2 years. However, benefit for children is less clear given limited studies and unclear current guidelines. We hypothesize there are identifiable risk ...
Full textLink to itemCite
Journal ArticleJ Adolesc Young Adult Oncol · June 2024
Purpose: Childhood, adolescent, and young adult (CAYA) cancer survivors (age 0-39 years at diagnosis) are at increased risk of cardiovascular disease (CVD). Family history of early heart disease increases the risk of CVD in the general population; however, ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · May 2024
BACKGROUND: Inherited cardiomyopathies present with broad variation of phenotype. Data are limited regarding genetic screening strategies and outcomes associated with predicted deleterious variants in cardiomyopathy-associated genes in the general populati ...
Full textLink to itemCite
Journal ArticlePediatr Cardiol · March 8, 2024
Anthracyclines are effective chemotherapeutics used in approximately 60% of pediatric cancer cases but have a well-documented risk of cardiotoxicity. Existing cardiotoxicity risk calculators do not include cardiovascular risk factors present at the time of ...
Full textLink to itemCite
Journal ArticleJACC Adv · February 2024
BACKGROUND: Thousands of genetic variants have been identified in cardiomyopathy-associated genes. Diagnostic genetic testing is key for evaluation of individuals with suspected cardiomyopathy. While accurate variant pathogenicity assignment is important f ...
Full textLink to itemCite
Journal ArticleJ Card Fail · December 2023
BACKGROUND: A diagnosis of Lamin proteins A and C cardiomyopathy (LMNA-CM) not only impacts disease prognosis, but also leads to specific guideline-recommended treatment options for these patients. This etiology is fundamentally different from other geneti ...
Full textLink to itemCite
Journal ArticleJACC Basic Transl Sci · December 2023
Junctional ectopic tachycardia (JET) is a potentially fatal cardiac arrhythmia. Hcn4:shJph2 mice serve as a model of nodal arrhythmias driven by ryanodine type 2 receptor (RyR2)-mediated Ca2+ leak. EL20 is a small molecule that blocks RyR2 Ca2+ leak. In a ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · December 2023
BACKGROUND: PRDM16 plays a role in myocardial development through TGF-β (transforming growth factor-beta) signaling. Recent evidence suggests that loss of PRDM16 expression is associated with cardiomyopathy development in mice, although its role in human c ...
Full textLink to itemCite
Journal ArticleGenome Med · October 23, 2023
BACKGROUND: As the availability of genomic testing grows, variant interpretation will increasingly be performed by genomic generalists, rather than domain-specific experts. Demand is rising for laboratories to accurately classify variants in inherited card ...
Full textLink to itemCite
Journal ArticleJACC CardioOncol · August 2023
BACKGROUND: It is unknown whether a history of childhood cancer modifies the established disparities in cardiovascular risk factors (CVRFs) observed in the general population. OBJECTIVES: We sought to determine if disparities in CVRFs by race/ethnicity are ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · August 2023
BACKGROUND: 1p36 deletion syndrome can predispose to pediatric-onset cardiomyopathy. Deletion breakpoints are variable and may delete the transcription factor PRDM16. Early studies suggest that deletion of PRDM16 may underlie cardiomyopathy in patients wit ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · August 2023
BACKGROUND: With genetic testing advancements, the burden of incidentally identified cardiac disease-associated gene variants is rising. These variants may carry a risk of sudden cardiac death, highlighting the need for accurate diagnostic interpretation. ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · May 2023
PURPOSE OF REVIEW: Congenital heart disease includes a wide variety of structural cardiac defects, the most severe of which are single ventricle defects (SVD). These patients suffer from significant morbidity and mortality; however, our understanding of th ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · April 2023
Rapid advances in genetic technologies have led to expanding use of diagnostic, research, and direct-to-consumer exome and genome sequencing. Incidentally identified variants from this sequencing represent a significant and growing challenge to interpret a ...
Full textLink to itemCite
Journal ArticlemedRxiv · September 1, 2024
BACKGROUND: Alternating hemiplegia of childhood (AHC) is a rare disorder with both neurologic and cardiac manifestations. The ATP1A3-D801N variant is associated with a pathologically short QT interval and risk of ventricular arrhythmia following bradycardi ...
Full textLink to itemCite
Journal ArticlemedRxiv · July 31, 2024
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition affecting ~1 in 500 and exhibits marked genetic heterogeneity. Previously published in 2019, 57 HCM-associated genes were curated providing the first systematic evaluation of g ...
Full textLink to itemCite
Journal ArticlePediatr Res · July 5, 2024
BACKGROUND: Despite advances in treatment and survival, individuals with congenital heart defects (CHD) have a higher risk of heart failure (HF) compared to the general population. OBJECTIVE: To evaluate comorbidities associated with HF in patients with CH ...
Full textLink to itemCite
ConferencePediatr Cardiol · June 2024
Adults with congenital heart disease (CHD) benefit from cardiology follow-up at recommended intervals of ≤ 2 years. However, benefit for children is less clear given limited studies and unclear current guidelines. We hypothesize there are identifiable risk ...
Full textLink to itemCite
Journal ArticleJ Adolesc Young Adult Oncol · June 2024
Purpose: Childhood, adolescent, and young adult (CAYA) cancer survivors (age 0-39 years at diagnosis) are at increased risk of cardiovascular disease (CVD). Family history of early heart disease increases the risk of CVD in the general population; however, ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · May 2024
BACKGROUND: Inherited cardiomyopathies present with broad variation of phenotype. Data are limited regarding genetic screening strategies and outcomes associated with predicted deleterious variants in cardiomyopathy-associated genes in the general populati ...
Full textLink to itemCite
Journal ArticlePediatr Cardiol · March 8, 2024
Anthracyclines are effective chemotherapeutics used in approximately 60% of pediatric cancer cases but have a well-documented risk of cardiotoxicity. Existing cardiotoxicity risk calculators do not include cardiovascular risk factors present at the time of ...
Full textLink to itemCite
Journal ArticleJACC Adv · February 2024
BACKGROUND: Thousands of genetic variants have been identified in cardiomyopathy-associated genes. Diagnostic genetic testing is key for evaluation of individuals with suspected cardiomyopathy. While accurate variant pathogenicity assignment is important f ...
Full textLink to itemCite
Journal ArticleJ Card Fail · December 2023
BACKGROUND: A diagnosis of Lamin proteins A and C cardiomyopathy (LMNA-CM) not only impacts disease prognosis, but also leads to specific guideline-recommended treatment options for these patients. This etiology is fundamentally different from other geneti ...
Full textLink to itemCite
Journal ArticleJACC Basic Transl Sci · December 2023
Junctional ectopic tachycardia (JET) is a potentially fatal cardiac arrhythmia. Hcn4:shJph2 mice serve as a model of nodal arrhythmias driven by ryanodine type 2 receptor (RyR2)-mediated Ca2+ leak. EL20 is a small molecule that blocks RyR2 Ca2+ leak. In a ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · December 2023
BACKGROUND: PRDM16 plays a role in myocardial development through TGF-β (transforming growth factor-beta) signaling. Recent evidence suggests that loss of PRDM16 expression is associated with cardiomyopathy development in mice, although its role in human c ...
Full textLink to itemCite
Journal ArticleGenome Med · October 23, 2023
BACKGROUND: As the availability of genomic testing grows, variant interpretation will increasingly be performed by genomic generalists, rather than domain-specific experts. Demand is rising for laboratories to accurately classify variants in inherited card ...
Full textLink to itemCite
Journal ArticleJACC CardioOncol · August 2023
BACKGROUND: It is unknown whether a history of childhood cancer modifies the established disparities in cardiovascular risk factors (CVRFs) observed in the general population. OBJECTIVES: We sought to determine if disparities in CVRFs by race/ethnicity are ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · August 2023
BACKGROUND: 1p36 deletion syndrome can predispose to pediatric-onset cardiomyopathy. Deletion breakpoints are variable and may delete the transcription factor PRDM16. Early studies suggest that deletion of PRDM16 may underlie cardiomyopathy in patients wit ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · August 2023
BACKGROUND: With genetic testing advancements, the burden of incidentally identified cardiac disease-associated gene variants is rising. These variants may carry a risk of sudden cardiac death, highlighting the need for accurate diagnostic interpretation. ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · May 2023
PURPOSE OF REVIEW: Congenital heart disease includes a wide variety of structural cardiac defects, the most severe of which are single ventricle defects (SVD). These patients suffer from significant morbidity and mortality; however, our understanding of th ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · April 2023
Rapid advances in genetic technologies have led to expanding use of diagnostic, research, and direct-to-consumer exome and genome sequencing. Incidentally identified variants from this sequencing represent a significant and growing challenge to interpret a ...
Full textLink to itemCite
Journal ArticleMol Genet Metab · March 2023
Glycogen storage disease type IV (GSD IV) is an ultra-rare autosomal recessive disorder caused by pathogenic variants in GBE1 which results in reduced or deficient glycogen branching enzyme activity. Consequently, glycogen synthesis is impaired and leads t ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · February 2023
BACKGROUND: Spontaneously depolarizing nodal cells comprise the pacemaker of the heart. Intracellular calcium (Ca2+) plays a critical role in mediating nodal cell automaticity and understanding this so-called Ca2+ clock is critical to understanding nodal a ...
Full textLink to itemCite
Journal ArticleTrends Cardiovasc Med · January 2023
Rare variants in JPH2 have been associated with a range of cardiac disease, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmias, and sudden cardiac death (SCD); however, our understanding of how variants in JPH2 correspon ...
Full textLink to itemCite
Journal ArticleAm J Hum Genet · December 1, 2022
The genotyping of millions of human samples has made it possible to evaluate variants across the human genome for their possible association with risks for numerous diseases and other traits by using genome-wide association studies (GWASs). The association ...
Full textLink to itemCite
Journal ArticleJ Pers Med · November 18, 2022
Rapid genome sequencing in critically ill infants is increasingly identified as a crucial test for providing targeted and informed patient care. We report the outcomes of a pilot study wherein eight critically ill neonates received rapid whole genome seque ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · October 4, 2022
Background As utilization of clinical exome sequencing (ES) has expanded, criteria for evaluating the diagnostic weight of incidentally identified variants are critical to guide clinicians and researchers. This is particularly important in genes associated ...
Full textLink to itemCite
Journal ArticleCurr Opin Genet Dev · October 2022
Pediatric sudden cardiac death (SCD) is the sudden unexpected death of a child or adolescent due to a presumed cardiac etiology. Heritable causes of pediatric SCD are predominantly cardiomyopathies and cardiac ion channelopathies. This review illustrates r ...
Full textLink to itemCite
Journal ArticleAm J Hum Genet · September 1, 2022
The vision of the American Society of Human Genetics (ASHG) is that people everywhere will realize the benefits of human genetics and genomics. Implicit in that vision is the importance of ensuring that the benefits of human genetics and genomics research ...
Full textLink to itemCite
Journal ArticleAANA J · August 2022
The following case report describes a 13-year-old child with alternating hemiplegia of childhood (AHC) who underwent magnetic resonance imaging MRI with general anesthesia and experienced a hemiplegic spell, seizure, apnea, and sudden cardiac arrest with s ...
Link to itemCite
Journal ArticleCirculation · July 12, 2022
BACKGROUND: There is a paucity of data regarding the phenotype of dilated cardiomyopathy (DCM) gene variants in the general population. We aimed to determine the frequency and penetrance of DCM-associated putative pathogenic gene variants in a general adul ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · June 2022
BACKGROUND: Accurately determining variant pathogenicity is critical in the diagnosis of cardiac channelopathies; however, it remains unknown how variant pathogenicity status changes over time. Our aim is to use a comprehensive analysis of ClinVar to under ...
Full textLink to itemCite
Journal ArticleSci Rep · May 17, 2022
Hypertrophic cardiomyopathy (HCM) is a genetic disease of the sarcomere that causes otherwise unexplained cardiac hypertrophy and is associated with sudden death. While previous studies showed the role of the epigenetic modifier Brg1 in mouse models of HCM ...
Full textLink to itemCite
Journal ArticleGenet Med · May 2022
PURPOSE: In a large cohort of 373 pediatric patients with Marfan syndrome (MFS) with a severe cardiovascular phenotype, we explored the proportion of patients with MFS with a pathogenic FBN1 variant and analyzed whether the type/location of FBN1 variants w ...
Full textLink to itemCite
Journal ArticleJ Pers Med · April 30, 2022
Background: Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and can predispose individuals to sudden death. Most pediatric HCM patients host a known pathogenic variant in a sarcomeric gene. With the increase in exome sequencin ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · April 15, 2022
The Norwood procedure with a right ventricular to pulmonary artery shunt (RVPAS) decreases early mortality, but requires a ventriculotomy, possibly increasing risk of ventricular arrhythmias (VAs) compared with the modified Blalock-Taussig shunt (MBTS). Th ...
Full textLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · April 2022
BACKGROUND: Cardiac channelopathies such as catecholaminergic polymorphic tachycardia and long QT syndrome predispose patients to fatal arrhythmias and sudden cardiac death. As genetic testing has become common in clinical practice, variants of uncertain s ...
Full textLink to itemCite
Journal ArticleMol Genet Metab · March 2022
PURPOSE: Thoroughly phenotype children with late-onset Pompe disease (LOPD) diagnosed via newborn screening (NBS) to provide guidance for long-term follow up. METHODS: Twenty infants ages 6-21 months with LOPD diagnosed by NBS underwent systematic clinical ...
Full textOpen AccessLink to itemCite
Journal ArticleNat Commun · February 2, 2022
Therapies for cardiac arrhythmias could greatly benefit from approaches to enhance electrical excitability and action potential conduction in the heart by stably overexpressing mammalian voltage-gated sodium channels. However, the large size of these chann ...
Full textLink to itemCite
Journal ArticleCirculation · November 16, 2021
Arrhythmogenic cardiomyopathy (ACM) is a primary disease of the myocardium, predominantly caused by genetic defects in proteins of the cardiac intercalated disc, particularly, desmosomes. Transmission is mostly autosomal dominant with incomplete penetrance ...
Full textLink to itemCite
Journal ArticleJCO Clin Cancer Inform · October 2021
PURPOSE: Cardiovascular disease is a significant cause of late morbidity and mortality in survivors of childhood cancer. Clinical informatics tools could enhance provider adherence to echocardiogram guidelines for early detection of late-onset cardiomyopat ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · October 2021
Genetic diseases that affect the cardiovascular system are relatively common and include cardiac channelopathies, cardiomyopathies, aortopathies, hypercholesterolemias, and structural diseases of the heart and great vessels. The rapidly expanding availabil ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · September 7, 2021
Background Pathogenic variation in the ATP1A3-encoded sodium-potassium ATPase, ATP1A3, is responsible for alternating hemiplegia of childhood (AHC). Although these patients experience a high rate of sudden unexpected death in epilepsy, the pathophysiologic ...
Full textOpen AccessLink to itemCite
Journal ArticleProg Pediatr Cardiol · September 2021
BACKGROUND: Pediatric-onset cardiomyopathies are rare yet cause significant morbidity and mortality in affected children. Genetic testing has a major role in the clinical evaluation of pediatric-onset cardiomyopathies, and identification of a variant in an ...
Full textOpen AccessLink to itemCite
Journal ArticlePhysiol Rep · September 2021
BACKGROUND: Dysfunction and inflammation of hearts subjected to cold ischemic preservation may differ between left and right ventricles, suggesting distinct strategies for amelioration. METHODS AND RESULTS: Explanted murine hearts subjected to cold ischemi ...
Full textLink to itemCite
Journal ArticleClin Genet · August 2021
Anthracyclines, chemotherapeutic agents that have contributed to significant improvements in cancer survival, also carry risk of both acute and chronic cardiotoxicity. This has led to significantly elevated risks of cardiac morbidity and mortality among ca ...
Full textLink to itemCite
Journal ArticleCirc Genom Precis Med · August 2021
Recent advances in next-genetic sequencing technology have facilitated an expansion in the use of exome and genome sequencing in the research and clinical settings. While this has aided in the genetic diagnosis of individuals with atypical clinical present ...
Full textLink to itemCite
Journal ArticleJ Cell Mol Med · June 10, 2021
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited cardiac arrhythmia syndrome that often leads to sudden cardiac death. The most common form of CPVT is caused by autosomal-dominant variants in the cardiac ryanodine receptor type- ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Muscle Res Cell Motil · June 2021
Familial cardiomyopathy is an inherited disease that affects the structure and function of heart muscle and has an extreme range of phenotypes. Among the millions of affected individuals, patients with hypertrophic (HCM), dilated (DCM), or left ventricular ...
Full textOpen AccessLink to itemCite
ConferenceJournal of Clinical Oncology · May 20, 2021
10017 Background: Racial, ethnic, and socioeconomic disparities are documented in outcomes for childhood cancer survivors. Understanding whether childhood cancer modifies established disparities in cardiovascular risk factors (CV ...
Full textCite
Journal ArticleAdv Med Sci · March 2021
The dystrophin-glycoprotein complex (DGC), situated at the sarcolemma dynamically remodels during cardiac disease. This review examines DGC remodeling as a common denominator in diseases affecting heart function and health. Dystrophin and the DGC serve as ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Med Genet A · March 2021
Long QT syndrome (LQTS) is a genetic disease resulting in a prolonged QT interval on a resting electrocardiogram, predisposing affected individuals to polymorphic ventricular tachycardia and sudden death. Although a number of genes have been implicated in ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Genom Precis Med · February 2021
BACKGROUND: TTN, the largest gene in the human body, encodes TTN (titin), a protein that plays key structural, developmental, and regulatory roles in skeletal and cardiac muscle. Variants in TTN, particularly truncating variants (TTNtvs), have been implica ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Heart Assoc · January 19, 2021
Congenital heart disease is the most common congenital defect observed in newborns. Within the spectrum of congenital heart disease are left-sided obstructive lesions (LSOLs), which include hypoplastic left heart syndrome, aortic stenosis, bicuspid aortic ...
Full textOpen AccessLink to itemCite
Journal Article · 2021
ABSTRACTBackground There is a paucity of data regarding the phenotype of dilated cardiomyopathy (DCM) gene variants in the general population. We aimed to determine the frequency and penetrance of DCM-associated putative pathogenic gene ...
Full textCite
Journal ArticleFront Pediatr · 2021
Background: Sudden infant death syndrome (SIDS) is the sudden, unexplained death of infants <1 year old. SIDS remains a leading cause of death in US infants. We aim to identify associations between SIDS and race/ethnicity, birth weight/gestational age, and ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC Clin Electrophysiol · November 2020
OBJECTIVES: This study sought to determine the relationship between long QT syndrome (LQTS) subtype (LTQ1, LTQ2, LTQ3) and postnatal cardiac events (CEs). BACKGROUND: LQTS presenting with 2:1 atrioventricular block or torsades de pointes in the fetus and/o ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation. Genomic and precision medicine · August 2020
Advances in human genetics are improving the understanding of a variety of inherited cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, and lipid disorders such as familial hypercholesterolemia. However, not all ...
Full textOpen AccessCite
Journal ArticleJ Mol Cell Cardiol · May 2020
INTRODUCTION: Troponin (TNN)-encoded cardiac troponins (Tn) are critical for sensing calcium and triggering myofilament contraction. TNN variants are associated with development of cardiomyopathy; however, recent advances in genetic analysis have identifie ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Rep · March 4, 2020
Status epilepticus (SE) is a prevalent disorder associated with significant morbidity, including the development of epilepsy and mortality. Cardiac arrhythmias (i.e. inappropriate sinus tachycardia and bradycardia, asystole, and atrioventricular blocks) ar ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Heart Assoc · March 3, 2020
Background Pediatric-onset restrictive cardiomyopathy (RCM) is associated with high mortality, but underlying mechanisms of disease are under investigated. RCM-associated diastolic dysfunction secondary to variants in TNNT2-encoded cardiac troponin T (TNNT ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation · February 11, 2020
BACKGROUND: Insight into type 5 long QT syndrome (LQT5) has been limited to case reports and small family series. Improved understanding of the clinical phenotype and genetic features associated with rare KCNE1 variants implicated in LQT5 was sought throug ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Card Fail · December 2019
BACKGROUND: Wolff-Parkinson-White (WPW) has been associated with left ventricular noncompaction (LVNC) in children. Little is known about the prevalence of this association, clinical outcomes, and treatment options. METHODS: Retrospective review of subject ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Rep · June 21, 2019
Junctophilin-2 (JPH2) is a part of the junctional membrane complex that facilitates calcium-handling in the cardiomyocyte. Previously, missense variants in JPH2 have been linked to hypertrophic cardiomyopathy; however, pathogenic "loss of function" (LOF) v ...
Full textOpen AccessLink to itemCite
Journal ArticleMol Genet Genomic Med · June 2019
BACKGROUND: With expanding use of clinical whole exome sequencing (WES), genetic variants of uncertain significance are increasingly identified. As pathologic mutations in genes associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) carry a ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Vis Exp · January 16, 2019
Advancements in the cost and speed of next generation genetic sequencing have generated an explosion of clinical whole exome and whole genome testing. While this has led to increased identification of likely pathogenic mutations associated with genetic syn ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Case Rep · January 2019
Variants of unknown significance in cardiomyopathic disease should be analyzed systematically based on the prevalence of the variant in the population compared to prevalence of disease, evidence that other variants in the gene are pathologic, consistency o ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · December 2018
BACKGROUND: Arrhythmias are common in the pediatric population. In patients unable to take oral medications or in need of acute therapy, options of intravenous (IV) antiarrhythmic medications are limited. Recently IV sotalol has become readily available, b ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Pediatr · November 2018
OBJECTIVE: To determine the prevalence, spectrum, and prognostic significance of copy number variants of undetermined significance (cnVUS) seen on chromosomal microarray (CMA) in neonates with hypoplastic left heart syndrome (HLHS). STUDY DESIGN: Neonates ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · July 2018
BACKGROUND: Due to rapid expansion of clinical genetic testing, an increasing number of genetic variants of undetermined significance and unclear diagnostic value are being identified in children. Variants found in genes associated with heritable channelop ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Rep · August 29, 2017
Anthracycline-based chemotherapy is associated with dose-dependent, irreversible damage to the heart. Childhood cancer survivors with hypertension after anthracycline exposure are at increased risk of cardiotoxicity, leading to the hypothesis that genetic ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Res · June 9, 2017
There has been a significant progress in our understanding of the molecular mechanisms by which calcium (Ca2+) ions mediate various types of cardiac arrhythmias. A growing list of inherited gene defects can cause potentially lethal cardiac arrhythmia syndr ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Arrhythm Electrophysiol · April 2017
BACKGROUND: The rapid expansion of genetic testing has led to increased utilization of clinical whole-exome sequencing (WES). Clinicians and genetic researchers are being faced with assessing risk of disease vulnerability from incidentally identified genet ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC Basic Transl Sci · February 2017
BACKGROUND: Hypertrophic cardiomyopathy (HCM), defined as asymmetric left ventricular hypertrophy, is a leading cause of cardiac death in the young. Perturbations in calcium (Ca2+) handling proteins have been implicated in the pathogenesis of HCM. JPH2-enc ...
Full textOpen AccessLink to itemCite
Journal ArticleFront Physiol · 2017
Mutations in TNNC1-the gene encoding cardiac troponin C (cTnC)-that have been associated with hypertrophic cardiomyopathy (HCM) and cardiac dysfunction may also affect Ca2+-regulation and function of slow skeletal muscle since the same gene is expressed in ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Cardiol · October 1, 2016
BACKGROUND: Mutations in the CACNA1C-encoded L-type calcium channel have been associated with Timothy syndrome (TS) with severe QT prolongation, syndactyly, facial dysmorphisms, developmental delay, and sudden death. Recently, patients hosting CACNA1C muta ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Physiol Heart Circ Physiol · November 1, 2014
Expression silencing of junctophilin-2 (JPH2) in mouse heart leads to ryanodine receptor type 2 (RyR2)-mediated sarcoplasmic reticulum (SR) Ca(2+) leak and rapid development of heart failure. The mechanism and physiological significance of JPH2 in regulati ...
Full textOpen AccessLink to itemCite
Journal ArticleCardiovasc Res · July 15, 2014
Cardiomyocytes rely on a highly specialized subcellular architecture to maintain normal cardiac function. In a little over a decade, junctophilin-2 (JPH2) has become recognized as a cardiac structural protein critical in forming junctional membrane complex ...
Full textOpen AccessLink to itemCite
Journal ArticleTrends Mol Med · June 2014
Excitable tissues rely on junctional membrane complexes to couple cell surface signals to intracellular channels. The junctophilins have emerged as a family of proteins critical in coordinating the maturation and maintenance of this cellular ultrastructure ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Cardiovasc Transl Res · April 2014
Despite the significant progress that has been made in identifying disease-associated mutations, the utility of the hypertrophic cardiomyopathy (HCM) genetic test is limited by a lack of understanding of the background genetic variation inherent to these s ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Coll Cardiol · November 19, 2013
OBJECTIVES: This study sought to study the role of junctophilin-2 (JPH2) in atrial fibrillation (AF). BACKGROUND: JPH2 is believed to have an important role in sarcoplasmic reticulum (SR) Ca(2+) handling and modulation of ryanodine receptor Ca(2+) channels ...
Full textOpen AccessLink to itemCite
Journal ArticleCardiovasc Res · October 1, 2013
AIMS: Transverse tubules (TTs) provide the basic subcellular structures that facilitate excitation-contraction (EC) coupling, the essential process that underlies normal cardiac contractility. Previous studies have shown that TTs develop within the first f ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Biol Chem · September 14, 2012
Defined as clinically unexplained hypertrophy of the left ventricle, hypertrophic cardiomyopathy (HCM) is traditionally understood as a disease of the cardiac sarcomere. Mutations in TNNC1-encoded cardiac troponin C (cTnC) are a relatively rare cause of HC ...
Full textOpen AccessLink to itemCite
Journal ArticleCurr Mol Med · June 2012
Traditionally regarded as a genetic disease of the cardiac sarcomere, hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease and a significant cause of sudden cardiac death. While the most common etiologies of this phenotypic ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Pharmacol Ther · October 2011
Although the etiologies of sudden cardiac death (SCD) are diverse, genetic mutations associated with cardiomyopathic and channelopathic diseases are major causes, and clinically available genetic tests offer the potential to identify at-risk family members ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Coll Cardiol · June 7, 2011
OBJECTIVES: The aims of this study were to determine the spectrum and prevalence of "background genetic noise" in the arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC) genetic test and to determine genetic associations that can guide the int ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Neuropathol Exp Neurol · April 2011
Mutations in dysferlin cause an inherited muscular dystrophy because of defective membrane repair. Three interacting partners of dysferlin are also implicated in membrane resealing: caveolin-3 (in limb girdle muscular dystrophy type 1C), annexin A1, and th ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation · March 8, 2011
BACKGROUND: Excitation-contraction coupling in striated muscle requires proper communication of plasmalemmal voltage-activated Ca2+ channels and Ca2+ release channels on sarcoplasmic reticulum within junctional membrane complexes. Although previous studies ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Heart Fail · March 2011
BACKGROUND: Junctophilin-2 (JPH2), a protein expressed in the junctional membrane complex, is necessary for proper intracellular calcium (Ca(2+)) signaling in cardiac myocytes. Downregulation of JPH2 expression in a model of cardiac hypertrophy was recentl ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · January 2011
BACKGROUND: hypertrophic cardiomyopathy (HCM) is a major cause of sudden death in young athletes and one of the most common inherited cardiovascular diseases, affecting 1 in 500 individuals. Often viewed as a disease of the cardiac sarcomere, mutations in ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation · December 7, 2010
Hypertrophic cardiomyopathy (HCM), or clinically unexplained hypertrophy of the heart, is a common genetic cardiovascular disorder marked by genetic and phenotypic heterogeneity. As the genetic mutations underlying the pathogenesis of this disease have bee ...
Full textOpen AccessLink to itemCite
Journal ArticlePhysiol Genomics · May 13, 2009
Junctophilins (JPHs) are members of a junctional membrane complex protein family important for the physical approximation of plasmalemmal and sarcoplasmic/endoplasmic reticulum membranes. As such, JPHs facilitate signal transduction in excitable cells betw ...
Full textLink to itemCite
Journal ArticleJ Mol Cell Cardiol · August 2008
Hypertrophic Cardiomyopathy (HCM) is a common primary cardiac disorder defined by a hypertrophied left ventricle, is one of the main causes of sudden death in young athletes, and has been associated with mutations in most sarcomeric proteins (tropomyosin, ...
Full textLink to itemCite
Journal ArticleLeuk Lymphoma · November 2007
In chemotherapy-treated patients with chronic myeloid leukemia (CML), the karyotypic detection of Philadelphia chromosome (Ph)-negative metaphases at diagnosis (i.e. Ph mosaicism) is not considered significant as a prognostic factor for survival. In the cu ...
Full textLink to itemCite
Journal ArticleNat Genet · August 2007
Noonan and LEOPARD syndromes are developmental disorders with overlapping features, including cardiac abnormalities, short stature and facial dysmorphia. Increased RAS signaling owing to PTPN11, SOS1 and KRAS mutations causes approximately 60% of Noonan sy ...
Full textLink to itemCite
Journal ArticleJ Mol Cell Cardiol · June 2007
Junctophilin-2 (JPH2) is a cardiac specific member of the junctophilins, a newly characterized family of junctional membrane complex proteins important in physically approximating the plasmalemmal L-type calcium channel and the sarcoplasmic reticulum ryano ...
Full textLink to itemCite
Journal ArticleLeuk Lymphoma · October 2006
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard in this regard is conventional bone marrow cytogenetics. Peripheral blood fluo ...
Full textLink to itemCite
Journal ArticleLeuk Lymphoma · March 2006
The unique molecular characteristic of chronic myeloid leukemia (CML), the disease-causing ABL (9q34) to BCR (22q11) translocation, has provided an invaluable tool for disease diagnosis and monitoring of treatment response. The traditional standard in this ...
Full textLink to itemCite